|
|
||||||||
through a TNF-
-Dependent Mechanism 1
Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267
Protection against certain intracellular pathogens can take place in the absence of IFN-
through mechanisms dependent on TNF-
. In this regard, patients with partial defect in IFN-
receptor 1 are not susceptible to toxoplasmosis. Thus, we used a model of Toxoplasma gondii infection to investigate whether CD154 modulates IFN-
-independent mechanisms of host protection. Human monocyte-derived macrophages treated with recombinant CD154 exhibited increased anti-T. gondii activity. The number of tachyzoites per 100 macrophages at 20 h postinfection was lower in CD154-treated macrophages compared with controls. This was accompanied by a decrease in the percentage of infected cells in CD154-treated macrophages at 20 h compared with 1 h postinfection. CD154-bearing cells also induced antimicrobial activity in T. gondii-infected macrophages. CD154 enhanced macrophage anti-T. gondii activity independently of IFN-
. TNF-
mediated the effects of CD154 on macrophage anti-T. gondii activity. CD154 increased TNF-
production by T. gondii-infected macrophages, and neutralization of TNF-
inhibited the effect of CD154 on macrophage anti-T. gondii activity. These results demonstrate that CD154 triggers TNF-
-dependent antimicrobial activity in macrophages and suggest that CD154 regulates the mechanisms of host protection that take place when IFN-
signaling is deficient.
This article has been cited by other articles:
![]() |
C. S. Subauste and M. Wessendarp CD40 Restrains In Vivo Growth of Toxoplasma gondii Independently of Gamma Interferon Infect. Immun., March 1, 2006; 74(3): 1573 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Danese, M. Sans, F. Scaldaferri, A. Sgambato, S. Rutella, A. Cittadini, J. M. Pique, J. Panes, J. A. Katz, A. Gasbarrini, et al. TNF-{alpha} Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn's Disease J. Immunol., February 15, 2006; 176(4): 2617 - 2624. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Andrade, M. Wessendarp, J.-A. C. Portillo, J.-Q. Yang, F. J. Gomez, J. E. Durbin, G. A. Bishop, and C. S. Subauste TNF Receptor-Associated Factor 6-Dependent CD40 Signaling Primes Macrophages to Acquire Antimicrobial Activity in Response to TNF-{alpha} J. Immunol., November 1, 2005; 175(9): 6014 - 6021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Andrade, J.-A. C. Portillo, M. Wessendarp, and C. S. Subauste CD40 Signaling in Macrophages Induces Activity against an Intracellular Pathogen Independently of Gamma Interferon and Reactive Nitrogen Intermediates Infect. Immun., May 1, 2005; 73(5): 3115 - 3123. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |